tiprankstipranks
TipRanksTop Financial ExpertsInsidersJohn Schmid

John Schmid Insider Profile

340 Followers
John Schmid, Director at BlossomHill Therapeutics, Inc., holds 6.00K shares in BlossomHill Therapeutics, Inc. (Ticker: BLSM), holds 37.65K shares in AnaptysBio (Ticker: ANAB), holds 37.65K shares in First Tracks Biotherapeutics Inc (Ticker: TRAX). Most recently, John Schmid Bought ― shares of BlossomHill Therapeutics, Inc. on Aug 10, 2026 for an estimated value of $96.00K.
See the Hottest Stocks Based on Insider Trading >
tipranks
John Schmid

John Schmid
BlossomHill Therapeutics, Inc. (BLSM)
Director

Ranked #1,188 out of 108,575 Corporate Insiders

Profitable Transactions

88%
7 out of 8 Profitable Transactions

Average Return

+94.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$6M
35.02%
26.05%
19.30%
13.88%
5.76% Others
A breakdown of John Schmid's holdings
See the Top Stocks by Insiders

Insider Roles

AnaptysBio
(ANAB)
Director
First Tracks Biotherapeutics Inc
(TRAX)
Director
Xeris Pharmaceuticals
(XERS)
Director
Design Therapeutics
(DSGN)
Director
+2 other positions
Roles that John Schmid holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Xeris Pharmaceuticals
(XERS)
Rating:Informative Buy
Date:Aug 12, 2024 - Aug 12, 2025
Return:+224.40%
The most profitable trade made by John Schmid
See the Latest Stocks Traded by Insiders

John Schmid's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BLSM
BlossomHill Therapeutics, Inc.
Aug 10, 2026
Director
Informative Buy
96.00K
$96.60K
ASPX
Auspex Pharma
May 05, 2015
―
Uninformative Sell
―
―
NEOS
Neos Therapeutics
Mar 19, 2021
―
Uninformative Sell
―
$0.00
ANAB
AnaptysBio
Jun 17, 2026
Director
Uninformative Buy
358.85K
$2.22M
XERS
Xeris Pharmaceuticals
Aug 13, 2024
Director
Informative Buy
10.11K
$1.22M
PSTX
Poseida Therapeutics
Jan 08, 2025
―
Uninformative Sell
―
$0.00
DSGN
Design Therapeutics
Mar 25, 2024
Director
Informative Buy
99.66K
$880.15K
BBOT
BridgeBio Oncology Therapeutics
Aug 11, 2025
Former Director
Uninformative Buy
301.80K
$268.50K
TRAX
First Tracks Biotherapeutics Inc
Jun 17, 2026
Director
Uninformative Buy
107.82K
$1.65M
TSRX
Trius Therap
Aug 02, 2010
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see John Schmid's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

John Schmid insider profile FAQ

What is the percentage of profitable transactions made by John Schmid?
The percentage of profitable transactions made by John Schmid is 88%.
    What is the average return per transaction made by John Schmid?
    The average return per transaction made by John Schmid is 94.40%.
      What stocks does John Schmid hold?
      John Schmid holds: BLSM, ASPX, NEOS, ANAB, XERS, PSTX, DSGN, BBOT, TRAX, TSRX stocks.
        What was John Schmid’s latest transaction?
        John Schmid latest transaction was an Informative Buy of $96.00K.
          What was John Schmid's most profitable transaction?
          John Schmid’s most profitable transaction was an Informative Buy of XERS stock on August 12, 2024. The return on the trade was 224.40%.
            What is John Schmid's role in BlossomHill Therapeutics, Inc.?
            John Schmid's role in BlossomHill Therapeutics, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.